John McDermott has decided to step down as CEO of Endologix Inc.
McDermott, who has been the CEO of the Irvine, Calif.-based company since May 2008, will remain in his position until a successor is found to ensure a smooth transition.
Endologix CEO steps down
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
John McDermott has decided to step down as CEO of Endologix Inc.
McDermott, who has been the CEO of the Irvine, Calif.-based company since May 2008, will remain in his position until a successor is found to ensure a smooth transition.